VER-3323
VER-3323 is a drug which acts as a selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with moderate selectivity for 5-HT2C, but relatively low affinity for 5-HT2A. It has potent anorectic effects in animal studies.[1][2][3][4]
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
Chemical and physical data | |
Formula | C11H15BrN2 |
Molar mass | 255.159 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
- Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (August 2004). "Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 370 (2): 114–23. doi:10.1007/s00210-004-0951-4. PMID 15322733.
- Halford JC, Harrold JA, Lawton CL, Blundell JE (March 2005). "Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity". Current Drug Targets. 6 (2): 201–13. doi:10.2174/1389450053174550. PMID 15777190.
- Schuhler S, Clark A, Joseph W, Patel A, Lehnen K, Stratford E, Horan TL, Fone KC, Ebling FJ (May 2005). "Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters". Journal of Neuroendocrinology. 17 (5): 276–85. doi:10.1111/j.1365-2826.2005.01303.x. PMID 15869562.
- Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A (December 2005). "Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes". ASSAY and Drug Development Technologies. 3 (6): 649–59. doi:10.1089/adt.2005.3.649. PMID 16438660.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.